亚洲 · 区域市场 · Pulse (Maeil Business)
Samsung Biologics raises 2026 revenue forecast to $4.1bn
Samsung Biologics Co. raised its 2026 revenue forecast by 148.4 billion won ($111.9 million) to 5.47 trillion won, up 20 percent from last year, citing full utilization of Plants…
在 Pulse (Maeil Business) 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (pulse.mk.co.kr)
